Hints and tips:
Related Special Reports
...US department store Kohl’s dipped 1.5 per cent after announcing its chief operating officer has left the company after less than a year in the role....
...PZ Cussons’ chief executive Jonathan Myers has described the devaluation of the naira as the company’s “most significant challenge”....
...Bristol Myers Squibb said on Wednesday that chief executive Giovanni Caforio would step down as chief executive on November 1 and be replaced by chief commercialisation officer Christopher Boerner....
...collections and partnered with concert venues, looked at music “in a slightly different way” for the launch of its Freelancer Pop bi-compax chronograph limited edition in July, says its chief marketing officer...
...Speaking at an industry conference last month, Liz Fernando, chief investment officer of Nest, the government-backed workplace pension fund, said the fund would not go into early-stage VC as it preferred...
...Rather, in February 2022 he was named chief executive of Hertz, the Fort Myers-based mainstay of the rental car business which had just emerged from bankruptcy and looked poised to take advantage of a post-pandemic...
...Netflix’s head of inclusion strategy, Vernā Myers, said she would step down in September to run her own consulting business while still advising the streaming group....
...Speakers include the chief financial officers of United Airlines, Riyadh Air and Wizz Air, plus executives from Southwest Airlines and IndiGo. One more thing . . ....
...He joins from O’Melveny & Myers. Law firm Simpson Thacher & Bartlett has named 32 new partners.* Law firm White & Case has named 42 new partners....
...board seats (FT) US law firms ask staff to spend more time in the office (FT) Advisers to Evergrande creditors warn of potential liquidation (FT) Odey to close wealth management business (FT) Bristol Myers...
...Bristol-Myers Squibb earlier this month agreed to buy Turning Point Therapeutics, which is developing a new cancer drug, for $4.1bn....
...“Planners can’t build houses,” says Michael Kiely, chair of the Planning Officers Society, a professional body. “We’ve done our job — a significant amount of applications are granted.”...
...In the early 1990s, Leavy served as a personal assistant to former President Bill Clinton’s press secretary, Dee Dee Myers....
...“We think that the Fed is done raising rates,” said Bob Michele, chief investment officer at JPMorgan Asset Management. “We see enough signs of inflation moderating....
...GSK, Pfizer and Bristol Myers Squibb were among other big pharmaceutical companies that stopped trying to find treatments for some of humanity’s most inscrutable diseases....
...One day after news of the merger broke, The Lawyer reported that A&O’s chief financial officer Donald Joyce, is leaving the firm. He’ll be replaced by US chief operating officer Bethan Chatters....
...Bristol-Myers Squibb has agreed to acquire Turning Point Therapeutics for $4.1bn in the latest in a series of bolt-on acquisitions by pharmaceutical companies looking to bolster their drug pipelines....
...Bristol-Myers Squibb reduced its full-year 2022 earnings forecasts citing stronger than expected generic competition for its former top selling cancer drug Revlimid, which recently lost exclusivity....
...After graduating in 2001, DeSantis taught history for a year at the Darlington school in Georgia, before going on to Harvard Law School and enrolling as a military legal officer of the type portrayed by...
...“Not saying anything is saying something,” said Laura Gitman, chief operating officer of BSR, a group which advises businesses on their social responsibilities....
...David Elkins, chief financial officer at Bristol-Myers Squibb, says the company remained optimistic about adding to its drug pipeline and did not see a big change in the regulatory environment....
...“That’s a double bonus,” says Magali Anderson, Holcim chief sustainability and innovation officer....
...However, Samit Hirawat, chief medical officer at drugmaker Bristol-Myers Squibb, warned that disruption may persist despite trial enrolment almost regaining pre-pandemic levels by the end of last year....
...“Fingers have been hovering over the sell trigger for the tech sector,” said Gregory Perdon, co-chief investment officer at Arbuthnot Latham....
International Edition